Cell line · CVCL_0554

T24

Cancer cell line, Homo sapiens. Bladder carcinoma. 144 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. T24. Cell lines, record CVCL_0554. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0554

On this page

Cell line

As Cellosaurus gives it.

Name: T24
Accession: CVCL_0554
RRID: RRID:CVCL_0554
Synonyms: T-24, T 24
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 82Y
Category: Cancer cell line
Diseases: Bladder carcinoma (NCIt C4912)
Derived from: Urinary bladder (in situ)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers144

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

Paper	Journal	Year	How we know	Source
Capsaicin enhances chemosensitivity and mitigates MMP11-driven aggressiveness in human bladder cancer.	Cancer Cell Int	2026	Its Methods give the RRID and name the line	PubMed
SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis.	Transl Androl Urol	2026	Its Methods give the RRID and name the line	PubMed
Isocyanate-Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3-Mediated Extracellular Matrix Remodeling and cGAS-STING Pathway Activation in Bladder Cancer.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
HRAS promotes mutant NRAS-driven transformation with codon and allele specificity.	Sci Signal	2026	Its Methods give the RRID and name the line	PubMed
Pentachlorophenol enhances bladder cancer cell invasion through altered protein stability.	iScience	2026	Its Methods give the RRID and name the line	PubMed
Enfortumab vedotin induces immunogenic cell death and shows enhanced preclinical antitumor activity when combined with a PD-1 inhibitor.	Cell Rep Med	2026	Its Methods give the RRID and name the line	PubMed
Rapid normal fibroblast-tumor crosstalk promotes cancer-associated fibroblast-like activation and attenuates mitomycin C cytotoxicity in bladder cancer.	J Cell Commun Signal	2026	Its Methods give the RRID and name the line	PubMed
Biophysical reprogramming of immunosuppressive neutrophils by cold atmospheric plasma reinvigorates antitumor immunity.	Sci Adv	2026	Its Methods give the RRID and name the line	PubMed
The YTHDC1/HECW1/SMAD7 axis drives cisplatin resistance in bladder cancer.	Transl Androl Urol	2026	Its Methods give the RRID and name the line	PubMed
The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function.	Pharmacol Res Perspect	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 144

See all 144 papers

Relatives41

Relation	Cell line	Accession	Problem	Source
Derived from it	ACCS	CVCL_6876	Has a recorded problem	Cell lines
Derived from it	ECV-304	CVCL_2029	Has a recorded problem	Cell lines
Derived from it	EDITGENE T24-CopGFP	CVCL_F6BT		Cell lines
Derived from it	EDITGENE T24-FLUC	CVCL_F5UA		Cell lines
Derived from it	EJ-1	CVCL_2893	Has a recorded problem	Cell lines
Derived from it	Ej138	CVCL_2443	Has a recorded problem	Cell lines
Derived from it	GHE	CVCL_8199	Has a recorded problem	Cell lines
Derived from it	HBMEC-2	CVCL_AT91	Has a recorded problem	Cell lines
Derived from it	HCV-29TMV	CVCL_8229	Has a recorded problem	Cell lines
Derived from it	Hu456	CVCL_8238	Has a recorded problem	Cell lines

1 to 10 of 41

See all 41 relatives

Cell banks16

Cell bank	Catalog number	Source
ABM	T8988	ABM
ATCC	HTB-4	ATCC
BCRC	60062	BCRC
BCRJ	0231	BCRJ
CCLV	CCLV-RIE 0062	Cellosaurus
CCTCC	GDC0078	Cellosaurus
CLS	300352	CLS
DSMZ	ACC-376	DSMZ
EDITGENE	EDC00298	EDITGENE
JCRB	JCRB0711	JCRB

1 to 10 of 16

See all 16 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0554

GET https://conductscience.org/api/cell-lines/v1/CVCL_0554/papers?page=2

API reference For AI assistants